Research Funded To Date

The Galactosemia Foundation has awarded over $601,000 to fund galactosemia related research.

2017

  • Towards individual prognostication in Classic Galactosemia

Dr. Annet Bosch

$51,271

  • Defining the role of Galactitol accumulation as a possible mediator of outcome in GALT null fruit flies

Dr. Fridovich-Keil

$30,000

  • Developing small molecule therapy for Classic Galactosemia by crystallography-based fragment screening 

Dr. Wyatt Yue

$35,000

  • Untargeted analysis of the Galactosemia micro-biome 

Dr. Sandy Van Calcar

$40,607

2015

  • Intervention and outcomes in classic galactosemia

Dr. Judith L. Fridovich-Keil

$30,000

  • In Vivo Efficacy and Safety Assessment of Small Molecule Inhibitors of Human Galactokinase

Dr. Kent Lai

$49,500

Dr. Annet Bosch

$10,875

2013

Dr. Gerard Berry

$48,800

Dr. Judith L. Fridovich-Keil

$40,361

Dr. Kent Lai

$33,000

Dr. Sanda Van Calcar

$20,292

2010

  • Evaluation of Nutrition Recommendations for Classic Galactosemia

Sandra Van Calcar

$27,000

  • The Brain and Neuro-functioning in Adults with Galactosemia

Dr. Susan Waisbren

$34,997

  • Computational Biology Strategy for the Development of Potential Drugs for People with Classical Galactosemia

Dr. Anna Marabotti

$41,500

2009

  • Health and Psychosocial Outcomes in Adults with Classic Galactosemia

Dr. Gerard Berry

$30,000

  • Galactosemia: Review of Outcomes and Development of Guidelines for Management of Educational and Behavioral Challenges

Dr. Susan Waisbren

$29,919

2007

Dr. Judith L. Fridovich-Keil

$50,000